A customized diabetes treatment is expected to revolutionize the treatment of kidney disease, sparing tens of thousands of dialysis and organ transplant hells, and saving hundreds annually.
And the British newspaper “Daily Mail” reported that directors of the National Health Service in Britain “NHS” granted the right to take the drug for about 91,000 patients in the country.
This approval came after a study found that taking a daily dose of the drug “dapagliflozin” reduced the risk of needing dialysis or transplantation and even death by 39 percent.
This drug is the first major development in the treatment of kidney disease in nearly 20 years.
Source: Sky News